Portfolio
EyeGate Pharma
Based in Waltham Massachusetts, EyeGate Pharma is developing a proprietary platform of medicines to treat diseases of the eye using its unique, non-invasive, iontophoretic drug-delivery system called EyeGate® II. This proprietary technology platform is based on over 10-years of development at the Bascom Palmer Eye Institute at the University of Miami and has been tested extensively in both preclinical and human studies in Europe.
| Industry : | Ophtalmologie |
| Location : | Paris et Waltham, Massachusetts |
| Funds : | Innoven FCPI 2002, 2003. Innoven Europe, Innoven Europe 2. FCPI Poste Innovation 1, 2, 3, 5, 6, 9. FCPI La Banque Postale Innovation 1 |
| Contact: | Walter Meier |
Read more about :
EyeGate Pharma
05/01/2012